Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$456K Sell
2,650
-6,800
-72% -$1.11M 0.46% 55
2017
Q1
$1.55M Buy
9,450
+5,650
+149% +$939K 1.44% 33
2016
Q4
$556K Sell
3,800
-5,650
-60% -$850K 0.54% 54
2016
Q3
$1.58M Buy
+9,450
New +$1.6M 1.59% 31

Other funds holding AMGN

First Houston Capital's AMGN Position: Q2 2017 in Review

First Houston Capital reduced its Amgen (AMGN) stake by 72% in Q2 2017, selling an estimated $1.11M and leaving 2,650 shares worth $456K. The position accounts for 0.46% of the portfolio, ranked #55.

First Houston Capital first reported a position in AMGN in Q3 2016 and has held it in 4 quarters since. The position peaked at $1.58M in Q3 2016. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • First Houston Capital held 2,650 shares of Amgen worth $456K as of Q2 2017.
  • First Houston Capital sold 6,800 Amgen shares in Q2 2017, an estimated $1.11M.
  • Amgen made up 0.46% of First Houston Capital's portfolio in Q2 2017, its #55 holding.
  • First Houston Capital first reported a position in Amgen in Q3 2016 and has held it in 4 quarters since.
  • First Houston Capital's Amgen position peaked at $1.58M in Q3 2016.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on First Houston Capital's 13F filing for Q2 2017, filed 7 Aug 2017.